Half-dose verteporfin photodynamic therapy for acute central serous chorioretinopathy: one-year results of a randomized controlled trial.

[1]  G. Silvestri,et al.  Photodynamic therapy for central serous chorioretinopathy using a reduced dose of verteporfin. , 2008, Canadian journal of ophthalmology. Journal canadien d'ophtalmologie.

[2]  T. Lai,et al.  SAFETY ENHANCED PHOTODYNAMIC THERAPY FOR CHRONIC CENTRAL SEROUS CHORIORETINOPATHY: One-Year Results of a Prospective Study , 2008, Retina.

[3]  L. Yannuzzi,et al.  KETOCONAZOLE IN THE TREATMENT OF CHRONIC IDIOPATHIC CENTRAL SEROUS CHORIORETINOPATHY , 2007, Retina.

[4]  A. Koh.  Photodynamic therapy for focal RPE leaks. , 2006, Ophthalmology.

[5]  M. Parodi,et al.  Choroidal ischemia after photodynamic therapy with verteporfin for choroidal neovascularization. , 2006, American journal of ophthalmology.

[6]  A. Tatham,et al.  The use of propranolol to treat central serous chorioretinopathy: an evaluation by serial OCT. , 2006, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

[7]  M. Colucciello.  Choroidal neovascularization complicating photodynamic therapy for central serous retinopathy. , 2006, Retina.

[8]  Michael D. Ober,et al.  Photodynamic therapy for focal retinal pigment epithelial leaks secondary to central serous chorioretinopathy. , 2005, Ophthalmology.

[9]  S. Karakucuk,et al.  The Changes of Pattern Electroretinography at the Early Stage of Photodynamic Therapy , 2005, Documenta Ophthalmologica.

[10]  S. Karakucuk,et al.  Electrooculography After Photodynamic Therapy , 2005, Documenta Ophthalmologica.

[11]  Jennifer I. Lim,et al.  Verteporfin therapy of subfoveal minimally classic choroidal neovascularization in age-related macular degeneration: 2-year results of a randomized clinical trial. , 2005, Archives of ophthalmology.

[12]  T. Lai,et al.  Transient reduction in retinal function revealed by multifocal electroretinogram after photodynamic therapy. , 2004, American journal of ophthalmology.

[13]  T. Lai,et al.  Choroidal vascular remodelling in central serous chorioretinopathy after indocyanine green guided photodynamic therapy with verteporfin: a novel treatment at the primary disease level , 2003, The British journal of ophthalmology.

[14]  G. Peyman,et al.  Ocular photodynamic therapy for serous macular detachment in the diffuse retinal pigment epitheliopathy variant of idiopathic central serous chorioretinopathy. , 2003, American journal of ophthalmology.

[15]  J. Slakter,et al.  INDOCYANINE GREEN ANGIOGRAPHY‐GUIDED PHOTODYNAMIC THERAPY FOR TREATMENT OF CHRONIC CENTRAL SEROUS CHORIORETINOPATHY: A Pilot Study , 2003, Retina.

[16]  M. Parodi,et al.  Photodynamic therapy in chronic central serous chorioretinopathy. , 2003, Retina.

[17]  J. Pikkel,et al.  Acetazolamide for central serous retinopathy. , 2002, Ophthalmology.

[18]  Ursula Schmidt-Erfurth,et al.  Dose-related structural effects of photodynamic therapy on choroidal and retinal structures of human eyes , 2002, Graefe’s Archive for Clinical and Experimental Ophthalmology.

[19]  U. Schmidt-Erfurth,et al.  Histopathological changes following photodynamic therapy in human eyes. , 2002, Archives of ophthalmology.

[20]  Timothy G Murray,et al.  FACTORS ASSOCIATED WITH REDUCED VISUAL ACUITY DURING LONG-TERM FOLLOW-UP OF PATIENTS WITH IDIOPATHIC CENTRAL SEROUS CHORIORETINOPATHY , 2002, Retina.

[21]  J. Slakter,et al.  Polypoidal choroidal vasculopathy masquerading as central serous chorioretinopathy. , 2000, Ophthalmology.

[22]  A. Mudun,et al.  Laser photocoagulation for persistent central serous retinopathy: results of long-term follow-up. , 1997, Ophthalmology.

[23]  A. Ho,et al.  Digital indocyanine green videoangiography of central serous chorioretinopathy , 1994 .

[24]  A. Brucker,et al.  Long-term follow-up of idiopathic central serous chorioretinopathy by fluorescein angiography. , 1989, Ophthalmology.

[25]  D. Robertson.  Argon laser photocoagulation treatment in central serous chorioretinopathy. , 1986, Ophthalmology.

[26]  H S Thompson,et al.  Visual function abnormalities in central serous retinopathy. , 1984, Archives of ophthalmology.

[27]  D. Ilstrup,et al.  Direct, indirect, and sham laser photocoagulation in the management of central serous chorioretinopathy. , 1983, American journal of ophthalmology.

[28]  Stephen Miller,et al.  Stereoscopic Atlas of Macular Diseases, Diagnosis and Treatment , 1978 .

[29]  J D Gass,et al.  Pathogenesis of disciform detachment of the neuroepithelium. , 1967, American journal of ophthalmology.

[30]  J. Pulido,et al.  The incidence of central serous chorioretinopathy in Olmsted County, Minnesota, 1980-2002. , 2008, Ophthalmology.

[31]  J. Kang,et al.  Chronic Central Serous Chorioretinopathy: Photodynamic Therapy , 2007 .

[32]  K. Argyle.  Safety enhanced photodynamic therapy with half dose verteporfin for chronic central serous chorioretinopathy: A short term pilot study , 2006 .

[33]  Amol D. Kulkarni,et al.  Ocular changes after photodynamic therapy. , 2006, Investigative ophthalmology & visual science.

[34]  J. Mora,et al.  Acetazolamide for central serous retinopathy , 2002 .

[35]  M. F. Shuler.  Polypoidal Choroidal Vasculopathy Masquerading as Central Serous Chorioretinopathy , 2001 .

[36]  T. Hasan,et al.  Localization of lipoprotein-delivered benzoporphyrin derivative in the rabbit eye. , 1997, Current eye research.

[37]  J. Flammer,et al.  Choroidal capillary and venous congestion in central serous chorioretinopathy. , 1996, American journal of ophthalmology.

[38]  J. Slakter,et al.  INDOCYANINE GREEN VIDEOANGIOGRAPHY OF OLDER PATIENTS WITH CENTRAL SEROUS CHORIORETINOPATHY , 1996, Retina.

[39]  F C Piccolino,et al.  CENTRAL SEROUS CHORIORETINOPATHY AND INDOCYANINE GREEN ANGIOGRAPHY , 1994, Retina.